Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

8.7%

2 terminated out of 23 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

7%

1 of 15 completed with results

Key Signals

1 with results88% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (6)
P 1 (6)
P 4 (1)

Trial Status

Completed15
Active Not Recruiting2
Recruiting2
Terminated2
Suspended1
Unknown1

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT06403436Phase 1Active Not Recruiting

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

NCT06007092Phase 1Recruiting

Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer

NCT04643015Active Not Recruiting

New Ways of Doing Magnetic Resonance Imaging in Children and Adults

NCT05578872Phase 1Completed

A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

NCT03172897Phase 4SuspendedPrimary

Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients

NCT03986879CompletedPrimary

Relationship of the Physical Activity Practice and Its Different Domains With Cardiac Autonomic Modulation

NCT04855929Phase 1Completed

A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.

NCT05817734RecruitingPrimary

Human Phenotype Project Study Protocol

NCT04958499Not ApplicableCompletedPrimary

Effectiveness of Bio-Healthy Park on Adult

NCT05641324Phase 1Terminated

A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)

NCT04819035Completed

Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University Hospital

NCT04804306Completed

Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC

NCT04276714Not ApplicableTerminated

Revofit™ System Evaluation on Residual Limb Pain in Amputee Patients

NCT04353388Completed

Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University

NCT04291417Completed

Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W

NCT03598192Not ApplicableCompleted

The Effect and Safety of the Four Points Transversus Abdominis Plane Block

NCT03535441Completed

HMGB1 Release From Hemorrhagic Shock Patients

NCT03119220Not ApplicableCompletedPrimary

Applying a Stress Framework to Health Behavior Change: A Fitbit Study

NCT02309164Not ApplicableCompleted

The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).

NCT01956227Phase 1Completed

Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior

Scroll to load more

Research Network

Activity Timeline